Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Peter Sever, Björn Dahlöf, Neil R Poulter et al. · The Lancet · 2003 · 3.8K citations

Thrombosis, Hypertension, Cardiovascular Disease +12

Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention

Vasilios G. Athyros, Athanasios A. Papageorgiou, Bodosakis R. Mercouris et al. · Current Medical Research and Opinion · 2002 · 529 citations

Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial???Lipid Lowering Arm (ASCOT-LLA)

Peter Sever, Bj rn Dahl f, Neil R Poulter et al. · Drugs · 2004 · 521 citations

Thrombosis, Hypertension, Health Policy +14

Evidence of Plasma CoQ10‐Lowering Effect by HMG‐CoA Reductase Inhibitors: A Double‐Blind, Placebo‐Controlled Study

Giovanni Ghirlanda, A. Oradei, Andrea Manto et al. · The Journal of Clinical Pharmacology · 1993 · 325 citations

Atorvastatin Decreases the Coenzyme Q10 Level in the Blood of Patients at Risk for Cardiovascular Disease and Stroke

Tatjana Rundek, Ali Naini, Ralph L. Sacco et al. · Archives of Neurology · 2004 · 226 citations